FDA Import Refusal SCS-1643622-5/11/1 — VIVOZAN
The FDA refused shipment SCS-1643622-5/11/1 from VIVOZAN (South Korea) on Jul 25, 2022. The refused product falls under Drugs and Biologics — LIDOCAINE. Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Jul 25, 2022
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 60QBJ07 LIDOCAINE
- Charges
- 75